GOVERNMENT CONTRACT / PURCHASE ORDER
TO PROCURE CRISPR GENE-EDITING OF THE ACVR1 AND TGFBR1 GENES IN ENDOMETRIAL CANCER CELL LINES FOR NHGRI.
Awarded to SYNTHEGO CORPORATION
$86.8K
Data last updated Oct 22, 2026 · Source: USAspending
- Company legal name
- SYNTHEGO CORPORATION
- UEI / CAGE
- RNDBNJAKTJC9 / Not reported
- Parent award
- Not reported
- Awarding agency
- Department of Health and Human Services
- Subagency
- National Institutes of Health
- Industry
- Other
- NAICS
- 541714
- PSC
- R499
- Performance period
- Not reported — Not reported
- Recipient address
- 3696A HAVEN AVE, REDWOOD CITY, SAN MATEO, CA, 94063
- Place of performance
- REDWOOD CITY, SAN MATEO, CA, 94063
- Source last modified
- Nov 3, 2026
Description
TO PROCURE CRISPR GENE-EDITING OF THE ACVR1 AND TGFBR1 GENES IN ENDOMETRIAL CANCER CELL LINES FOR NHGRI.
Derived from official transactions
Contract lifecycle
- Award announced
TO PROCURE CRISPR GENE-EDITING OF THE ACVR1 AND TGFBR1 GENES IN ENDOMETRIAL CANCER CELL LINES FOR NHGRI.
- Value increased
TO PROCURE CRISPR GENE-EDITING OF THE ACVR1 AND TGFBR1 GENES IN ENDOMETRIAL CANCER CELL LINES FOR NHGRI.
Point-in-time model
Contract change outlook
Uncollapsed source history
Transactions and modifications
| Action date | Modification | Action type | Exact obligation | Current total | Potential total | Description | Source |
|---|---|---|---|---|---|---|---|
| Jul 29, 2021 | 0 | Not reported | $86,750.00 | Not reported | Not reported | TO PROCURE CRISPR GENE-EDITING OF THE ACVR1 AND TGFBR1 GENES IN ENDOMETRIAL CANCER CELL LINES FOR NHGRI. | USAspending ↗ |